1[1]Goldman J M.Therapeutic strategies for chronic myeloid leukemia in the chronic(stable) Phase[J].Siminars in Hematology,2003,40(1)Suppl 1:10.
2[2]O' brien S G,Deininger M W N.Imatinib in patients with newly diagnosed chronic phase chronic myeloid leukemia[J].Seminars in Hematology,2003,40 (2) Suppl 2:26.
3[3]Talpaz M,Silver R T,Druker B J,et al.Imatinib induces durable hematologies and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia:results of a phase2 study[J].Blood,2002,99(6):1928.
4[4]Kantarjian H M,Cortes J E,O'Brien S,et al.Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase[J].Blood,2002,99 (10):3547.
5[5]Kantarjian H M,Cortes J E,O'Brien S,et al.Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome -positive chronic myelogenous leukemia:high incidence of early complete and major cytogenetic responses[J].Blood,2003,101(1):97.
